Similar articles

• Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role.

  Brain SD, Cambridge H. Brain SD, et al. Gen Pharmacol. 1996 Jun;27(4):607-11. doi: 10.1016/0306-3623(95)00125-5. Gen Pharmacol. 1996. PMID: 8853291 Review.
• Effect of calcitonin gene-related peptide receptor antagonism on the systemic blood pressure responses to mechanistically diverse vasomodulators in conscious rats.

  Lynch JJ Jr, Detwiler TJ, Kane SA, Regan CP. Lynch JJ Jr, et al. J Cardiovasc Pharmacol. 2010 Nov;56(5):518-25. doi: 10.1097/FJC.0b013e3181f5d414. J Cardiovasc Pharmacol. 2010. PMID: 20729756
• Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: development of novel spiropiperidines.

  Burgey CS, Potteiger CM, Deng JZ, Mosser SD, Salvatore CA, Yu S, Roller S, Kane SA, Vacca JP, Williams TM. Burgey CS, et al. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6368-72. doi: 10.1016/j.bmcl.2009.09.066. Epub 2009 Sep 22. Bioorg Med Chem Lett. 2009. PMID: 19818613
• Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors.

  Chin SY, Hall JM, Brain SD, Morton IK. Chin SY, et al. J Pharmacol Exp Ther. 1994 Jun;269(3):989-92. J Pharmacol Exp Ther. 1994. PMID: 8014885
• Making headway - a role for CGRP in post-traumatic headache.

  Mitsikostas DD, Moskowitz MA. Mitsikostas DD, et al. Nat Rev Neurol. 2021 Mar;17(3):133-134. doi: 10.1038/s41582-020-00431-2. Nat Rev Neurol. 2021. PMID: 33199891 Review. No abstract available.